nsv6314253
- Organism: Homo sapiens
- Study:nstd102 (Clinical Structural Variants)
- Variant Type:complex chromosomal rearrangement
- Method Type:Multiple
- Submitted on:GRCh37
- Variant Calls:2
- Validation:Not tested
- Clinical Assertions: Yes
- Region Size:1
- Description:46;XY;inv(9)(p21.2p22.1) AND Encephalopathy
- Publication(s):Redin et al. 2016
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 120 SVs from 22 studies. See in: genome view
Overlapping variant regions from other studies: 120 SVs from 22 studies. See in: genome view
Overlapping variant regions from other studies: 104 SVs from 25 studies. See in: genome view
Overlapping variant regions from other studies: 103 SVs from 25 studies. See in: genome view
Overlapping variant regions from other studies: 126 SVs from 22 studies. See in: genome view
Overlapping variant regions from other studies: 126 SVs from 22 studies. See in: genome view
Overlapping variant regions from other studies: 110 SVs from 26 studies. See in: genome view
Overlapping variant regions from other studies: 109 SVs from 26 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop | strand |
---|---|---|---|---|---|---|---|---|---|---|
nsv6314253 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000009.12 | Chr9 | 18,469,960 | 18,469,960 | + |
nsv6314253 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000009.12 | Chr9 | 18,469,975 | 18,469,975 | - |
nsv6314253 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000009.12 | Chr9 | 26,866,235 | 26,866,235 | - |
nsv6314253 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000009.12 | Chr9 | 26,872,458 | 26,872,458 | + |
nsv6314253 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000009.11 | Chr9 | 18,469,958 | 18,469,958 | + | ||
nsv6314253 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000009.11 | Chr9 | 18,469,973 | 18,469,973 | - | ||
nsv6314253 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000009.11 | Chr9 | 26,866,233 | 26,866,233 | - | ||
nsv6314253 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000009.11 | Chr9 | 26,872,456 | 26,872,456 | + |
Variant Call Information
Variant Call ID | Type | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv17975304 | inversion | Multiple | Multiple | Encephalopathy; Encephalopathy | Uncertain significance | ClinVar | RCV000258551.1, VCV000267985.1 |
nssv17975305 | inversion | Multiple | Multiple | Encephalopathy; Encephalopathy | Uncertain significance | ClinVar | RCV000258551.1, VCV000267985.1 |
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop |
---|---|---|---|---|---|---|---|---|---|
nssv17975304 | Remapped | Perfect | NC_000009.12:g.268 66235inv525NC_0000 09.12:g.18469960in v525 | GRCh38.p12 | First Pass | NC_000009.12 | Chr9 | 18,469,960 | 18,469,960 |
nssv17975305 | Remapped | Perfect | NC_000009.12:g.184 69975inv619NC_0000 09.12:g.26872458in v619 | GRCh38.p12 | First Pass | NC_000009.12 | Chr9 | 18,469,975 | 18,469,975 |
nssv17975304 | Remapped | Perfect | NC_000009.12:g.268 66235inv525NC_0000 09.12:g.18469960in v525 | GRCh38.p12 | First Pass | NC_000009.12 | Chr9 | 26,866,235 | 26,866,235 |
nssv17975305 | Remapped | Perfect | NC_000009.12:g.184 69975inv619NC_0000 09.12:g.26872458in v619 | GRCh38.p12 | First Pass | NC_000009.12 | Chr9 | 26,872,458 | 26,872,458 |
nssv17975304 | Submitted genomic | NC_000009.11:g.184 69958inv525NC_0000 09.11:g.26866233in v525 | GRCh37 (hg19) | NC_000009.11 | Chr9 | 18,469,958 | 18,469,958 | ||
nssv17975305 | Submitted genomic | NC_000009.11:g.268 72456inv619NC_0000 09.11:g.18469973in v619 | GRCh37 (hg19) | NC_000009.11 | Chr9 | 18,469,973 | 18,469,973 | ||
nssv17975304 | Submitted genomic | NC_000009.11:g.184 69958inv525NC_0000 09.11:g.26866233in v525 | GRCh37 (hg19) | NC_000009.11 | Chr9 | 26,866,233 | 26,866,233 | ||
nssv17975305 | Submitted genomic | NC_000009.11:g.268 72456inv619NC_0000 09.11:g.18469973in v619 | GRCh37 (hg19) | NC_000009.11 | Chr9 | 26,872,456 | 26,872,456 |
No validation data were submitted for this variant
Clinical Assertions
Variant Call ID | HGVS | Type | Allele Origin | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv17975304 | GRCh37: NC_000009.11:g.18469958inv525NC_000009.11:g.26866233inv525 | inversion | unknown | Encephalopathy; Encephalopathy | Uncertain significance | ClinVar | RCV000258551.1, VCV000267985.1 |
nssv17975305 | GRCh37: NC_000009.11:g.26872456inv619NC_000009.11:g.18469973inv619 | inversion | unknown | Encephalopathy; Encephalopathy | Uncertain significance | ClinVar | RCV000258551.1, VCV000267985.1 |